+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Global Cell Therapy Market 2024-2028

  • PDF Icon

    Report

  • 166 Pages
  • August 2024
  • Region: Global
  • TechNavio
  • ID: 5553791
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cell therapy market is forecasted to grow by USD 84.58 billion during 2023-2028, accelerating at a CAGR of 73.89% during the forecast period. The report on the cell therapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by limitations in traditional organ transplantations fueling demand for cell therapies, increasing funding in cell-based research, and proven effectiveness of car t-cell therapy.

The cell therapy market is segmented as below:

By Type

  • Autologous
  • Allogenic

By Application

  • Malignancies
  • Musculoskeletal
  • Cardiovascular
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the increasing focus on cell therapy products as one of the prime reasons driving the cell therapy market growth during the next few years. Also, strategic alliances in cell therapy market and rise in vaccine production will lead to sizable demand in the market.

The report on the cell therapy market covers the following areas:

  • Cell therapy market sizing
  • Cell therapy market forecast
  • Cell therapy market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cell therapy market vendors that include Astellas Pharma Inc., Athersys Inc., Avita Medical Inc., BioCardia Inc., BioSenic SA, Brainstorm Cell Therapeutics Inc., Bristol Myers Squibb Co., Capricor Therapeutics Inc., Castle Creek Biosciences Inc., CellSeed Inc., Cellular Biomedicine Group Inc., Celyad Oncology SA, Gilead Sciences Inc., Lineage Cell Therapeutics Inc., Lisata Therapeutics Inc., Mesoblast Ltd., Novartis AG, Pharmicell Co. Ltd., Sanpower Group Co. Ltd., and ThermoGenesis Holdings Inc. Also, the cell therapy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Cell Therapy Market 2018 - 2022
Historic Market Size - Data Table on Global Cell Therapy Market 2018 - 2022 ($ million)
4.2 Type segment analysis 2018 - 2022
Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.3 Application segment analysis 2018 - 2022
Historic Market Size - Application Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Type
6.1 Market segments
Chart on Type - Market share 2023-2028 (%)
Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
6.3 Autologous - Market size and forecast 2023-2028
Chart on Autologous - Market size and forecast 2023-2028 ($ million)
Data Table on Autologous - Market size and forecast 2023-2028 ($ million)
Chart on Autologous - Year-over-year growth 2023-2028 (%)
Data Table on Autologous - Year-over-year growth 2023-2028 (%)
6.4 Allogenic - Market size and forecast 2023-2028
Chart on Allogenic - Market size and forecast 2023-2028 ($ million)
Data Table on Allogenic - Market size and forecast 2023-2028 ($ million)
Chart on Allogenic - Year-over-year growth 2023-2028 (%)
Data Table on Allogenic - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by Application
7.1 Market segments
Chart on Application - Market share 2023-2028 (%)
Data Table on Application - Market share 2023-2028 (%)
7.2 Comparison by Application
Chart on Comparison by Application
Data Table on Comparison by Application
7.3 Malignancies - Market size and forecast 2023-2028
Chart on Malignancies - Market size and forecast 2023-2028 ($ million)
Data Table on Malignancies - Market size and forecast 2023-2028 ($ million)
Chart on Malignancies - Year-over-year growth 2023-2028 (%)
Data Table on Malignancies - Year-over-year growth 2023-2028 (%)
7.4 Musculoskeletal - Market size and forecast 2023-2028
Chart on Musculoskeletal - Market size and forecast 2023-2028 ($ million)
Data Table on Musculoskeletal - Market size and forecast 2023-2028 ($ million)
Chart on Musculoskeletal - Year-over-year growth 2023-2028 (%)
Data Table on Musculoskeletal - Year-over-year growth 2023-2028 (%)
7.5 Cardiovascular - Market size and forecast 2023-2028
Chart on Cardiovascular - Market size and forecast 2023-2028 ($ million)
Data Table on Cardiovascular - Market size and forecast 2023-2028 ($ million)
Chart on Cardiovascular - Year-over-year growth 2023-2028 (%)
Data Table on Cardiovascular - Year-over-year growth 2023-2028 (%)
7.6 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ million)
Data Table on Others - Market size and forecast 2023-2028 ($ million)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
7.7 Market opportunity by Application
Market opportunity by Application ($ million)
Data Table on Market opportunity by Application ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Chart on Japan - Market size and forecast 2023-2028 ($ million)
Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Chart on Japan - Year-over-year growth 2023-2028 (%)
Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints
11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business
12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 Astellas Pharma Inc.
Astellas Pharma Inc. - Overview
Astellas Pharma Inc. - Product / Service
Astellas Pharma Inc. - Key news
Astellas Pharma Inc. - Key offerings
12.4 Athersys Inc.
Athersys Inc. - Overview
Athersys Inc. - Product / Service
Athersys Inc. - Key offerings
12.5 Avita Medical Inc.
Avita Medical Inc. - Overview
Avita Medical Inc. - Product / Service
Avita Medical Inc. - Key offerings
12.6 BioCardia Inc.
BioCardia Inc. - Overview
BioCardia Inc. - Product / Service
BioCardia Inc. - Key offerings
12.7 BioSenic SA
BioSenic SA - Overview
BioSenic SA - Product / Service
BioSenic SA - Key offerings
12.8 Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc. - Overview
Brainstorm Cell Therapeutics Inc. - Product / Service
Brainstorm Cell Therapeutics Inc. - Key offerings
12.9 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
12.10 Capricor Therapeutics Inc.
Capricor Therapeutics Inc. - Overview
Capricor Therapeutics Inc. - Product / Service
Capricor Therapeutics Inc. - Key offerings
12.11 Castle Creek Biosciences Inc.
Castle Creek Biosciences Inc. - Overview
Castle Creek Biosciences Inc. - Product / Service
Castle Creek Biosciences Inc. - Key offerings
12.12 CellSeed Inc.
CellSeed Inc. - Overview
CellSeed Inc. - Product / Service
CellSeed Inc. - Key offerings
12.13 Cellular Biomedicine Group Inc.
Cellular Biomedicine Group Inc. - Overview
Cellular Biomedicine Group Inc. - Product / Service
Cellular Biomedicine Group Inc. - Key offerings
12.14 Celyad Oncology SA
Celyad Oncology SA - Overview
Celyad Oncology SA - Product / Service
Celyad Oncology SA - Key offerings
12.15 Gilead Sciences Inc.
Gilead Sciences Inc. - Overview
Gilead Sciences Inc. - Product / Service
Gilead Sciences Inc. - Key news
Gilead Sciences Inc. - Key offerings
12.16 Lineage Cell Therapeutics Inc.
Lineage Cell Therapeutics Inc. - Overview
Lineage Cell Therapeutics Inc. - Product / Service
Lineage Cell Therapeutics Inc. - Key offerings
12.17 Lisata Therapeutics Inc.
Lisata Therapeutics Inc. - Overview
Lisata Therapeutics Inc. - Product / Service
Lisata Therapeutics Inc. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by Application
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Company Market Positioning
Exhibits 10: Parent Market
Exhibits 11: Data Table on - Parent Market
Exhibits 12: Market characteristics analysis
Exhibits 13: Value Chain Analysis
Exhibits 14: Offerings of companies included in the market definition
Exhibits 15: Market segments
Exhibits 16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 20: Historic Market Size - Data Table on Global Cell Therapy Market 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Application Segment 2018 - 2022 ($ million)
Exhibits 23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 25: Five forces analysis - Comparison between 2023 and 2028
Exhibits 26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 31: Chart on Market condition - Five forces 2023 and 2028
Exhibits 32: Chart on Type - Market share 2023-2028 (%)
Exhibits 33: Data Table on Type - Market share 2023-2028 (%)
Exhibits 34: Chart on Comparison by Type
Exhibits 35: Data Table on Comparison by Type
Exhibits 36: Chart on Autologous - Market size and forecast 2023-2028 ($ million)
Exhibits 37: Data Table on Autologous - Market size and forecast 2023-2028 ($ million)
Exhibits 38: Chart on Autologous - Year-over-year growth 2023-2028 (%)
Exhibits 39: Data Table on Autologous - Year-over-year growth 2023-2028 (%)
Exhibits 40: Chart on Allogenic - Market size and forecast 2023-2028 ($ million)
Exhibits 41: Data Table on Allogenic - Market size and forecast 2023-2028 ($ million)
Exhibits 42: Chart on Allogenic - Year-over-year growth 2023-2028 (%)
Exhibits 43: Data Table on Allogenic - Year-over-year growth 2023-2028 (%)
Exhibits 44: Market opportunity by Type ($ million)
Exhibits 45: Data Table on Market opportunity by Type ($ million)
Exhibits 46: Chart on Application - Market share 2023-2028 (%)
Exhibits 47: Data Table on Application - Market share 2023-2028 (%)
Exhibits 48: Chart on Comparison by Application
Exhibits 49: Data Table on Comparison by Application
Exhibits 50: Chart on Malignancies - Market size and forecast 2023-2028 ($ million)
Exhibits 51: Data Table on Malignancies - Market size and forecast 2023-2028 ($ million)
Exhibits 52: Chart on Malignancies - Year-over-year growth 2023-2028 (%)
Exhibits 53: Data Table on Malignancies - Year-over-year growth 2023-2028 (%)
Exhibits 54: Chart on Musculoskeletal - Market size and forecast 2023-2028 ($ million)
Exhibits 55: Data Table on Musculoskeletal - Market size and forecast 2023-2028 ($ million)
Exhibits 56: Chart on Musculoskeletal - Year-over-year growth 2023-2028 (%)
Exhibits 57: Data Table on Musculoskeletal - Year-over-year growth 2023-2028 (%)
Exhibits 58: Chart on Cardiovascular - Market size and forecast 2023-2028 ($ million)
Exhibits 59: Data Table on Cardiovascular - Market size and forecast 2023-2028 ($ million)
Exhibits 60: Chart on Cardiovascular - Year-over-year growth 2023-2028 (%)
Exhibits 61: Data Table on Cardiovascular - Year-over-year growth 2023-2028 (%)
Exhibits 62: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 63: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 64: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 65: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 66: Market opportunity by Application ($ million)
Exhibits 67: Data Table on Market opportunity by Application ($ million)
Exhibits 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 69: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 70: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 71: Chart on Geographic comparison
Exhibits 72: Data Table on Geographic comparison
Exhibits 73: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 74: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 75: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 76: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 77: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 78: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 79: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 80: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 81: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 82: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 83: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 85: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 86: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 87: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 88: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 89: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 90: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 91: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 92: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 93: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 94: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 95: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 96: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 97: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 98: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 99: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 100: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 101: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 102: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 103: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 104: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 105: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 106: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 107: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 108: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 109: Market opportunity By Geographical Landscape ($ million)
Exhibits 110: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 111: Impact of drivers and challenges in 2023 and 2028
Exhibits 112: Overview on criticality of inputs and factors of differentiation
Exhibits 113: Overview on factors of disruption
Exhibits 114: Impact of key risks on business
Exhibits 115: Companies covered
Exhibits 116: Matrix on companies position and classification
Exhibits 117: Astellas Pharma Inc. - Overview
Exhibits 118: Astellas Pharma Inc. - Product / Service
Exhibits 119: Astellas Pharma Inc. - Key news
Exhibits 120: Astellas Pharma Inc. - Key offerings
Exhibits 121: Athersys Inc. - Overview
Exhibits 122: Athersys Inc. - Product / Service
Exhibits 123: Athersys Inc. - Key offerings
Exhibits 124: Avita Medical Inc. - Overview
Exhibits 125: Avita Medical Inc. - Product / Service
Exhibits 126: Avita Medical Inc. - Key offerings
Exhibits 127: BioCardia Inc. - Overview
Exhibits 128: BioCardia Inc. - Product / Service
Exhibits 129: BioCardia Inc. - Key offerings
Exhibits 130: BioSenic SA - Overview
Exhibits 131: BioSenic SA - Product / Service
Exhibits 132: BioSenic SA - Key offerings
Exhibits 133: Brainstorm Cell Therapeutics Inc. - Overview
Exhibits 134: Brainstorm Cell Therapeutics Inc. - Product / Service
Exhibits 135: Brainstorm Cell Therapeutics Inc. - Key offerings
Exhibits 136: Bristol Myers Squibb Co. - Overview
Exhibits 137: Bristol Myers Squibb Co. - Product / Service
Exhibits 138: Bristol Myers Squibb Co. - Key news
Exhibits 139: Bristol Myers Squibb Co. - Key offerings
Exhibits 140: Capricor Therapeutics Inc. - Overview
Exhibits 141: Capricor Therapeutics Inc. - Product / Service
Exhibits 142: Capricor Therapeutics Inc. - Key offerings
Exhibits 143: Castle Creek Biosciences Inc. - Overview
Exhibits 144: Castle Creek Biosciences Inc. - Product / Service
Exhibits 145: Castle Creek Biosciences Inc. - Key offerings
Exhibits 146: CellSeed Inc. - Overview
Exhibits 147: CellSeed Inc. - Product / Service
Exhibits 148: CellSeed Inc. - Key offerings
Exhibits 149: Cellular Biomedicine Group Inc. - Overview
Exhibits 150: Cellular Biomedicine Group Inc. - Product / Service
Exhibits 151: Cellular Biomedicine Group Inc. - Key offerings
Exhibits 152: Celyad Oncology SA - Overview
Exhibits 153: Celyad Oncology SA - Product / Service
Exhibits 154: Celyad Oncology SA - Key offerings
Exhibits 155: Gilead Sciences Inc. - Overview
Exhibits 156: Gilead Sciences Inc. - Product / Service
Exhibits 157: Gilead Sciences Inc. - Key news
Exhibits 158: Gilead Sciences Inc. - Key offerings
Exhibits 159: Lineage Cell Therapeutics Inc. - Overview
Exhibits 160: Lineage Cell Therapeutics Inc. - Product / Service
Exhibits 161: Lineage Cell Therapeutics Inc. - Key offerings
Exhibits 162: Lisata Therapeutics Inc. - Overview
Exhibits 163: Lisata Therapeutics Inc. - Product / Service
Exhibits 164: Lisata Therapeutics Inc. - Key offerings
Exhibits 165: Inclusions checklist
Exhibits 166: Exclusions checklist
Exhibits 167: Currency conversion rates for US$
Exhibits 168: Research methodology
Exhibits 169: Information sources
Exhibits 170: Data validation
Exhibits 171: Validation techniques employed for market sizing
Exhibits 172: Data synthesis
Exhibits 173: 360 degree market analysis
Exhibits 174: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global cell therapy market: Astellas Pharma Inc., Athersys Inc., Avita Medical Inc., BioCardia Inc., BioSenic SA, Brainstorm Cell Therapeutics Inc., Bristol Myers Squibb Co., Capricor Therapeutics Inc., Castle Creek Biosciences Inc., CellSeed Inc., Cellular Biomedicine Group Inc., Celyad Oncology SA, Gilead Sciences Inc., Lineage Cell Therapeutics Inc., Lisata Therapeutics Inc., Mesoblast Ltd., Novartis AG, Pharmicell Co. Ltd., Sanpower Group Co. Ltd., and ThermoGenesis Holdings Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing focus on cell therapy products."

According to the report, one of the major drivers for this market is the limitations in traditional organ transplantations fueling demand for cell therapies.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Astellas Pharma Inc.
  • Athersys Inc.
  • Avita Medical Inc.
  • BioCardia Inc.
  • BioSenic SA
  • Brainstorm Cell Therapeutics Inc.
  • Bristol Myers Squibb Co.
  • Capricor Therapeutics Inc.
  • Castle Creek Biosciences Inc.
  • CellSeed Inc.
  • Cellular Biomedicine Group Inc.
  • Celyad Oncology SA
  • Gilead Sciences Inc.
  • Lineage Cell Therapeutics Inc.
  • Lisata Therapeutics Inc.
  • Mesoblast Ltd.
  • Novartis AG
  • Pharmicell Co. Ltd.
  • Sanpower Group Co. Ltd.
  • ThermoGenesis Holdings Inc.